Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04191834 alone and with naproxen for knee osteoarthritis pain
2010-020475-23Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PF-04191834 in knee osteoarthritis (OA) (4 arms), sponsored by Pfizer. Primary endpoint: Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) Osteoarthritis Index pain score. Started Aug 2010; status: terminated.
02
Drugs
PF-04191834
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2010-020475-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020475-23.